Law Offices of Thomas J. Lamb

  • Free Case Evaluation
  • Mesothelioma & Asbestos Diseases
  • Legal Compensation
  • Asbestos Overview
  • Common Questions
  • About Our Firm

Malignant Mesothelioma Mortality in Women — United States, 1999–2020

October 4, 2022 By Thomas Lamb

Inhalation of asbestos fibers can cause malignant mesothelioma, a rapidly progressing and lethal cancer of the mesothelium, the thin layer of tissues surrounding internal organs in the chest and abdomen. Patients with malignant mesothelioma have a poor prognosis, with a median survival of 1 year from diagnosis. The estimated median interval from … [Read more...]

Filed Under: Facts, Mesothelioma Tagged With: malignant mesothelioma, mesothelioma

The silent malignant mesothelioma epidemic: a call to action

September 6, 2022 By Thomas Lamb

Malignant mesothelioma, recognised as a new disease in the 1950s, is almost exclusively caused by asbestos exposure and usually diagnosed decades after first exposure. The disease was initially restricted to asbestos workers, but diagnoses after non-occupational exposure continue to surge. Despite the acknowledgment by WHO and the International … [Read more...]

Filed Under: Asbestos, Mesothelioma Tagged With: asbestos, asbestos exposure, malignant mesothelioma, mesothelioma

A Case Report of Hypophosphatemia Leading to the Diagnosis of Mesothelioma

June 8, 2022 By Thomas Lamb

Hypophosphatemia can be commonly encountered as an electrolyte imbalance and is defined as a value less than 0.8 mmol/l (2.5 mg/dl). It can be an incidental finding, but it is not uncommon to see it presenting with varied symptoms. It is good to have a clear diagnostic approach to this so adequate treatment can be instated. We present a … [Read more...]

Filed Under: Medicine, Mesothelioma Tagged With: hypophosphatemia, malignant mesothelioma, mesothelioma, mesothelioma diagnosis

CDC: Mesothelioma Deaths Up Among Women

May 13, 2022 By Thomas Lamb

While use of asbestos has gone down in the U.S., deaths from mesothelioma still increased 25% among women over the last two decades, researchers found. From 1999 to 2020, mesothelioma deaths among women rose significantly from 489 to 614, though the age-adjusted death rate per 1 million women fell from 4.83 to 4.15, reported Jacek Mazurek, MD, … [Read more...]

Filed Under: Facts, Mesothelioma Tagged With: malignant mesothelioma, mesothelioma

Unexplained Pleural Effusion Leads to the Revelation of a Malignant Mesothelioma: A Case Report

April 29, 2022 By Thomas Lamb

Abstract:  Malignant mesothelioma is a rare and aggressive cancer that usually affects subjects with prior asbestos exposure, a major risk factor that has been widely known as carcinogenic, and its use is now controlled if not banned in many areas of the world. Malignant mesothelioma originates from mesothelial surface cells covering the serous … [Read more...]

Filed Under: Medicine, Mesothelioma Tagged With: malignant mesothelioma, mesothelioma diagnosis, pleural effusions

Pericardial Mesothelioma Presenting as Constrictive Pericarditis

April 21, 2022 By Thomas Lamb

Abstract:  This case report presents a 60-year-old gentleman with a significant smoking history and possible asbestos exposure who was referred to the emergency department for atrial fibrillation with a rapid ventricular rate and symptoms of heart failure. Labs showed normal brain natriuretic peptide and troponin I. His echocardiography finding … [Read more...]

Filed Under: Medicine, Mesothelioma Tagged With: malignant mesothelioma, mesothelioma, mesothelioma diagnosis, pericardial mesothelioma

Abemaciclib for Previously Treated Patients With p16ink4A-Deficient Mesothelioma

April 15, 2022 By Thomas Lamb

As reported in The Lancet Oncology by Dean A. Fennell, FRCP, and colleagues, a phase II trial (MiST2) showed the activity of [ Verzenio (abemaciclib) ] in previously treated patients with p16ink4A-deficient malignant mesothelioma. As stated by the investigators, “Genetically stratified therapy for malignant mesothelioma is unavailable. … [Read more...]

Filed Under: Medicine, Mesothelioma Tagged With: abemaciclib, malignant mesothelioma, mesothelioma, mesothelioma treatments, Verzenio

Early Clinical Activity With CDK4/6 Inhibitor in Pretreated Mesothelioma

March 11, 2022 By Thomas Lamb

[Verzenio (abemaciclib), a drug that has proven effective in breast cancer,] showed preliminary activity in its first-ever clinical trial in mesothelioma. The cyclin-dependent kinase (CDK) 4/6 inhibitor [Verzenio (abemaciclib)] achieved disease control at 12 weeks in 14 of 26 patients with progressive mesothelioma associated with a CDKN2A … [Read more...]

Filed Under: Medicine, Mesothelioma Tagged With: abemaciclib, malignant mesothelioma, mesothelioma, mesothelioma treatments, Verzenio

Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study

February 14, 2022 By Thomas Lamb

Introduction:  Malignant mesothelioma (MM) is an aggressive cancer that primarily arises from the pleura (MPM) or peritoneum (MPeM), mostly due to asbestos exposure. This study reviewed the Dutch population-based incidence, treatment and survival since the national ban on asbestos in 1993. Materials and methods:  Patients with MPM or MPeM … [Read more...]

Filed Under: Medicine, Mesothelioma Tagged With: asbestos exposure, malignant mesothelioma, mesothelioma, mesothelioma diagnosis, mesothelioma treatments, peritoneal mesothelioma, pleural mesothelioma

Malignant pleural mesothelioma patients’ experience by gender: findings from a cross-sectional UK-national questionnaire

January 27, 2022 By Thomas Lamb

OBJECTIVES: Malignant mesothelioma is an aggressive malignancy of mesothelial surfaces, most commonly those of the pleura. The aim of this study was to understand, using a national questionnaire, the gendered care experiences of patients with malignant pleural mesothelioma (MPM). Patients were asked about their experience of the diagnostic process, … [Read more...]

Filed Under: Mesothelioma Tagged With: malignant mesothelioma, mesothelioma

Next Page »

Do I Have A Possible Case?

If you have a possible asbestos disease or mesothelioma lawsuit, you can get a free, confidential, and no obligation case review from asbestos lawyer Tom Lamb.

Main Navigation Menu

  • Who Was Exposed to Asbestos
  • NC Asbestos Exposure Sites
  • Asbestos-Contaminated Talc
  • Asbestos Diseases
  • Legal Compensation
  • Free Case Evaluation
  • Frequently Asked Questions
  • About Our Law Firm
  • Attorney Tom Lamb
  • Collection of Articles
  • Sitemap

Attorney Tom Lamb

TJL@LambLawOffice.com

Phone: 800-426-9535

Lumina Station, Suite 225
1908 Eastwood Road
Wilmington, North Carolina

Please know that you can use our Quick Contact Form to tell us about your case.

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Website

Lamb Law Office

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Disclaimer and Copyright Notices
  • Sitemap

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.